Non-Invasive Evaluation of Fibrosis and Steatosis in Chronic Hepatopathy
NCT01246388 · Status: UNKNOWN · Type: OBSERVATIONAL · Enrollment: 50
Last updated 2014-10-21
Summary
The purpose of this study is to evaluate non-invasive parameters for staging and grading of chronic hepatopathy in comparison to liver biopsy.
Conditions
- Chronic Liver Disease
- Steatohepatitis
- Fibrosis
Sponsors & Collaborators
-
Tischendorf, Jens, M.D.
lead INDIV
Principal Investigators
-
Holger H Lutz, M.D. · Department of Medicine III, University Hospital RTWH University of Aachen
Eligibility
- Min Age
- 18 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2010-05-31
- Primary Completion
- 2014-09-30
- Completion
- 2014-12-31
Countries
- Germany
Study Locations
More Related Trials
-
FibroScan in Patients With Hepatitis B and C Presenting for Liver Biopsy
NCT00125762 ·Status: COMPLETED ·Phase: NA
-
Magnetic Resonance Imaging in the Evaluation of Liver Fibrosis
NCT01572064 ·Status: COMPLETED ·Phase: NA
-
Non-invasive Evaluation of Liver Fibrosis, Steatosis, and NASH in NAFLD
NCT03725631 ·Status: UNKNOWN ·Phase: NA
-
Point-of-care Ultrasound Screening and Assessment of Chronic Liver Diseases and NASH
NCT05120557 ·Status: UNKNOWN ·Phase: NA
-
Noninvasive Evaluation of Hepatic Fibrosis in Chronic Hepatitis C
NCT00399815 ·Status: UNKNOWN
-
Multicenter Clinical Study on Noninvasive Assessment of Hepatic Steatosis and Fibrosis Using Visual Transient Elastography
NCT07128108 ·Status: RECRUITING
-
Comparison of Hepatus and FibroScan for Evaluation of Fibrosis and Steatosis
NCT05786963 ·Status: UNKNOWN
-
Fatty Liver and Ectopic Fat in Overweight and Obese Patients
NCT00886301 ·Status: COMPLETED ·Phase: NA
-
Comparative and Additive Diagnostic Performance of Magnetic Resonance Elastography (MRE) and Corrected-T1 (cT1) for Fibrosis and Inflammation in Nonalcoholic Steatohepatitis (NASH) Using Histology As Reference
NCT04389593 ·Status: COMPLETED
-
Competitive Accuracy of Radiological Imaging Compared to Liver Biopsy in Patients With Liver Fibrosis
NCT05008263 ·Status: COMPLETED
-
Non-Invasive Assessment of Graft Fibrosis After Living Donor Liver Transplantation
NCT03176290 ·Status: COMPLETED
-
Precise Evaluation Criteria for Histological Regression of NASH Fibrosis
NCT06364462 ·Status: NOT_YET_RECRUITING
-
Non-invasive Diagnostic Model of Liver Fibrosis Associated With NAFLD and Prediction of Prognosis
NCT03842748 ·Status: UNKNOWN
-
Biomarkers of Steatohepatitis in Type 2 Diabetes Patients
NCT07098520 ·Status: NOT_YET_RECRUITING
-
Hepatic Steatosis and Chronic Hepatitis B Virus
NCT05678582 ·Status: COMPLETED
-
Cost Effective Non Invasive Diagnostic Modalities and Predictive Model for Development and Progression of Fibrosis Among Patients With Hepatitis B, Hepatitis C Infection or Non Alcoholic Fatty Liver Disease
NCT02658786 ·Status: WITHDRAWN
-
Acoustic Liver Biopsy in Normals and in Patients With Cirrhosis Using Endoscopic Ultrasound
NCT01208311 ·Status: COMPLETED
-
Prevalence of Nonalcoholic Fatty Liver Disease (NAFLD) and Nonalcoholic Steatohepatitis (NASH) Utilizing Ultrasound and Percutaneous Liver Biopsy
NCT01100398 ·Status: COMPLETED
-
A Study to Evaluate Liver Stiffness With Shear Wave Elastography
NCT05097963 ·Status: COMPLETED ·Phase: NA
-
Combining MRI Steatosis Assessment and Transient Elastography to Improve Liver Fibrosis Diagnosis in Non Alcoholic Fatty Liver Disease
NCT03245606 ·Status: COMPLETED
-
Evaluation of 4 MRI Methods (PDFF 3, 6 and 11 Gradient Echoes and Spectroscopy) Compared to the Reference Method (Liver Biopsy) in Quantification of Hepatic Steatosis
NCT03142698 ·Status: UNKNOWN ·Phase: NA
-
Liver Fibrosis Assessment With ShearWave Elastography
NCT02181452 ·Status: COMPLETED
-
Liver Fibrosis in Peri-menopausal Women
NCT03602573 ·Status: UNKNOWN
-
Non-invasive Liver Screening Using FibroScan Device for Liver Disease Patients for the Steatosis/Fibrosis Database
NCT02897908 ·Status: RECRUITING
-
Prospective, Cross-sectional and Multicenter Study, Evaluating the Diagnosis Accuracy of the Controlled Attenuation Parameter(CAP) Measured by FibroScan® (Either With M+ or XL+ Probe) in Patient With Non-Alcoholic Fatty Liver Disease Using Liver Biopsy as Reference.
NCT01985009 ·Status: COMPLETED ·Phase: NA